Dr Lal PathLabs announces final dividend of ₹6 per equity share; check record date

Dr Lal PathLabs, a leading diagnostic chain, has recommended a final dividend of ₹6 per share for the financial year ended March 31, 2025.

The dividend was announced along with the results for the latest January-March quarter during the market hours on Thursday, April 25.

Dr Lal PathLabs announces dividend; check record date

In a regulatory filing, the company said its Board has recommended a "final dividend of ₹6 per equity share (@ 60% on a face value of ₹10 each) for the financial year ended March 31, 2025, subject to approval of the Members of the Company at ensuing Annual General Meeting."

The record date for the purpose of payment of dividend is June 6.

The final dividend will be paid within 30 days of the approval by the members, the company said.

Dr Lal PathLabs share price

The stock settled 1.39% higher at ₹2,827 per unit on the National Stock Exchange (NSE).

The company's market capitalisation stands at ₹23,631.38 crore.

Dr Lal PathLabs results

The company reported an 81.4% increase in consolidated net profit to ₹156 crore in Q4 FY25, compared to ₹86 crore in the year-ago period.

Revenue from operations advanced 10.5% to ₹603 crore in the reporting quarter as against ₹545 crore in the corresponding period of the last fiscal year.

Earnings before interest, taxes, depreciation, and amortisation (EBITDA) rose 16.9% to ₹169 crore in the last quarter of FY25, compared to ₹145 crore in the same period previous year. EBITDA margin was 28.1% vs 26.5% in Q4 FY24.

As on March 31, the company has 298 clinical laboratories, 6,607 patient service centres (PSCs) and 12,365 Pick-up Points (PUPs).